121 related articles for article (PubMed ID: 3921673)
1. Chelate conjugates of monoclonal antibodies for imaging lymphoid structures in the mouse.
Goodwin DA; Meares CF; McCall MJ; Haseman MK; McTigue M; Diamanti CI; Chaovapong W
J Nucl Med; 1985 May; 26(5):493-502. PubMed ID: 3921673
[TBL] [Abstract][Full Text] [Related]
2. Biological properties of biotin-chelate conjugates for pretargeted diagnosis and therapy with the avidin/biotin system.
Goodwin DA; Meares CF; Osen M
J Nucl Med; 1998 Oct; 39(10):1813-8. PubMed ID: 9776294
[TBL] [Abstract][Full Text] [Related]
3. Metabolism of indium chelates attached to monoclonal antibody: minimal transchelation of indium from benzyl-EDTA chelate in vivo.
Deshpande SV; Subramanian R; McCall MJ; DeNardo SJ; DeNardo GL; Meares CF
J Nucl Med; 1990 Feb; 31(2):218-24. PubMed ID: 2107283
[TBL] [Abstract][Full Text] [Related]
4. Microdistribution of specific rat monoclonal antibodies to mouse tissues and human tumor xenografts.
Kennel SJ; Falcioni R; Wesley JW
Cancer Res; 1991 Mar; 51(5):1529-36. PubMed ID: 1997194
[TBL] [Abstract][Full Text] [Related]
5. Human sarcoma-associated murine monoclonal antibody labeled with indium-111, gallium-67, and iodine-125.
Bartal AH; Lavie E; Boazi M; Weininger J; Bitton M; Iosilevsky G; Front D; Hirshaut Y; Robinson E
NCI Monogr; 1987; (3):153-5. PubMed ID: 3821913
[TBL] [Abstract][Full Text] [Related]
6. Distribution of radiolabeled human and mouse monoclonal IgM antibodies in murine models.
Halpern SE; Hagan PL; Chen A; Birdwell CR; Bartholomew RM; Burnett KG; David GS; Poggenburg K; Merchant B; Carlo DJ
J Nucl Med; 1988 Oct; 29(10):1688-96. PubMed ID: 3171697
[TBL] [Abstract][Full Text] [Related]
7. Optimization of monoclonal antibody delivery via the lymphatics: the dose dependence.
Steller MA; Parker RJ; Covell DG; Holton OD; Keenan AM; Sieber SM; Weinstein JN
Cancer Res; 1986 Apr; 46(4 Pt 1):1830-4. PubMed ID: 3948166
[TBL] [Abstract][Full Text] [Related]
8. Clinical parameters related to optimal tumor localization of indium-111-labeled mouse antimelanoma monoclonal antibody ZME-018.
Murray JL; Rosenblum MG; Lamki L; Glenn HJ; Krizan Z; Hersh EM; Plager CE; Bartholomew RM; Unger MW; Carlo DJ
J Nucl Med; 1987 Jan; 28(1):25-33. PubMed ID: 3794809
[TBL] [Abstract][Full Text] [Related]
9. Stability, characterization, and kinetics of 111In-labeled monoclonal antitumor antibodies in normal animals and nude mouse-human tumor models.
Halpern SE; Hagan PL; Garver PR; Koziol JA; Chen AW; Frincke JM; Bartholomew RM; David GS; Adams TH
Cancer Res; 1983 Nov; 43(11):5347-55. PubMed ID: 6616469
[TBL] [Abstract][Full Text] [Related]
10. Use of antibody as carrier of oligomers of peptidomimetic alphavbeta3 antagonist to target tumor-induced neovasculature.
Shin IS; Jang BS; Danthi SN; Xie J; Yu S; Le N; Maeng JS; Hwang IS; Li KC; Carrasquillo JA; Paik CH
Bioconjug Chem; 2007; 18(3):821-8. PubMed ID: 17375899
[TBL] [Abstract][Full Text] [Related]
11. Rapid and specific targeting of 125I-labeled B lymphocyte stimulator to lymphoid tissues and B cell tumors in mice.
Riccobene TA; Miceli RC; Lincoln C; Knight Y; Meadows J; Stabin MG; Sung C
J Nucl Med; 2003 Mar; 44(3):422-33. PubMed ID: 12621010
[TBL] [Abstract][Full Text] [Related]
12. Tumor size: effect on monoclonal antibody uptake in tumor models.
Hagan PL; Halpern SE; Dillman RO; Shawler DL; Johnson DE; Chen A; Krishnan L; Frincke J; Bartholomew RM; David GS
J Nucl Med; 1986 Mar; 27(3):422-7. PubMed ID: 3486953
[TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo targeting of radiolabeled monovalent and divalent haptens with dual specificity monoclonal antibody conjugates: enhanced divalent hapten affinity for cell-bound antibody conjugate.
Le Doussal JM; Martin M; Gautherot E; Delaage M; Barbet J
J Nucl Med; 1989 Aug; 30(8):1358-66. PubMed ID: 2787847
[TBL] [Abstract][Full Text] [Related]
14. Preparation and properties of antitumor monoclonal antibodies labeled with metallic radionuclides indium-111, gallium-67, and technetium-99m.
Endo K; Sakahara H; Nakashima T; Koizumi M; Ohta H; Kawamura Y; Kunimatsu M; Furukawa T; Ohmomo Y; Arano Y
NCI Monogr; 1987; (3):135-40. PubMed ID: 3469526
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the in vivo biodistribution of indium-111 and yttrium-88 labeled dendrimer-1B4M-DTPA and its conjugation with anti-Tac monoclonal antibody.
Kobayashi H; Wu C; Kim MK; Paik CH; Carrasquillo JA; Brechbiel MW
Bioconjug Chem; 1999; 10(1):103-11. PubMed ID: 9893971
[TBL] [Abstract][Full Text] [Related]
16. Effect of mass of 111In-benzyl-EDTA monoclonal antibody on hepatic uptake and processing in mice.
Adams GP; DeNardo SJ; Deshpande SV; DeNardo GL; Meares CF; McCall MJ; Epstein AL
Cancer Res; 1989 Apr; 49(7):1707-11. PubMed ID: 2493983
[TBL] [Abstract][Full Text] [Related]
17. Labeling of monoclonal antibodies with samarium-153 for combined radioimmunoscintigraphy and radioimmunotherapy.
Boniface GR; Izard ME; Walker KZ; McKay DR; Sorby PJ; Turner JH; Morris JG
J Nucl Med; 1989 May; 30(5):683-91. PubMed ID: 2785586
[TBL] [Abstract][Full Text] [Related]
18. Targeting of murine radiolabeled monoclonal antibodies in the lymphatics.
Parker RJ; Keenan AM; Dower SK; Steller MA; Holton OD; Sieber SM; Weinstein JN
Cancer Res; 1987 Apr; 47(8):2073-6. PubMed ID: 3828997
[TBL] [Abstract][Full Text] [Related]
19. Metal decomposition rates of 111In-DTPA and EDTA conjugates of monoclonal antibodies in vivo.
Goodwin DA; Meares CF; McTigue M; McCall MJ; Chaovapong W
Nucl Med Commun; 1986 Nov; 7(11):831-8. PubMed ID: 3106867
[TBL] [Abstract][Full Text] [Related]
20. Antilymphocytic antibodies and marrow transplantation. VI. Absence of immunosuppression in vivo after injection of monoclonal antibodies blocking graft-versus-host reactions and humoral antibody formation in vitro.
Thierfelder S; Hoffmann-Fezer G; Rodt H; Doxiadis I; Eulitz M; Kummer U
Transplantation; 1983 Mar; 35(3):249-54. PubMed ID: 6340277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
